Dalfampridine Tablet, Extended Release
Product Images NDC 42571-275

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 42571-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dalfampridine Figure1

A bar chart comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline between placebo and Dalfampridine Extended Release 10 mg b.i.d. groups. The X-axis shows increasing thresholds from 0% to 60%, while the Y-axis represents the percentage of patients. The chart includes p-values indicating statistical significance at each threshold.*

FDA Label Image

Dalfampridine Figure2

A bar graph comparing the percentage of patients achieving various thresholds of average percent increase in walking speed from baseline between placebo and dalfampridine extended release tablets 10 mg b.i.d. The x-axis shows increasing walking speed percent thresholds (≥ 0%, ≥ 10%, ≥ 20%, etc.), and the y-axis shows the corresponding percentage of patients. Values are higher in the dalfampridine group at most thresholds with associated p-values indicating statistical differences.*

FDA Label Image

Label (Dalfampridine Lbl)

Dalfampridine Extended-Release Tablets 10 mg label showing key drug information. The label includes dosage form, strength, and manufacturer details: Micro Labs Limited, India, and Micro Labs USA, Inc., New Jersey. It specifies 60 tablets per container and features warnings about tablet use and storage conditions. The NDC number 42571-275-60 and barcodes are also present.*

FDA Label Image

Dalfampridine Structure

Chemical structure of dalfampridine showing a six-membered aromatic ring with one nitrogen atom and an amino group (NH2) attached to the ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.